Skip to content
  • Clinical Studies
  • Schedule M
  • Stability Studies
  • Pharma GMP
  • Pharma Tips
  • Pharma Books
  • Pharma Validation
  • Pharma Regulatory

SOP Guide for Pharma

The Ultimate Resource for Pharmaceutical SOPs and Best Practices

  • Home
  • Job Safety Analysis (JSA)
    • Oral Dosage Forms (Tablets & Capsules)
    • Oral Liquid Dosage Forms (Syrups, Elixirs, Suspensions, Emulsions)
    • Powder and Granule Dosage Forms
    • Topical Dosage Forms (Creams, Ointments, Gels, Lotions, Pastes)
    • Transdermal Dosage Forms (Patches)
  • Standard Test Procedures (STP)
  • SOP – Blog Post
  • Toggle search form

Elixir Department: SOP for Recording Dispensed Quantities in BMR – V 2.0

Posted on By

Elixir Department: SOP for Recording Dispensed Quantities in BMR – V 2.0

Standard Operating Procedure for Recording Dispensed Quantities in Batch Manufacturing Record (BMR)

Department Elixir Department
SOP No. SOP/ELX/043/2025
Supersedes SOP/ELX/043/2022
Page No. Page 1 of 8
Issue Date 11/04/2025
Effective Date 15/04/2025
Review Date 11/04/2026

1. Purpose

To define the procedure for accurately recording dispensed material quantities in the Batch Manufacturing Record (BMR) in the Elixir Department, ensuring traceability, compliance with cGMP, and documentation integrity.

2. Scope

This SOP applies to all materials dispensed for use in elixir formulations including active ingredients, excipients, solvents, and preservatives. It is applicable to production and quality assurance personnel involved in BMR documentation.

3. Responsibilities

  • Dispensing Operator:
    • Enter the actual dispensed quantities into the BMR as per batch requirements.
  • Supervisor:
    • Verify and countersign the recorded entries for accuracy and completeness.
  • QA Officer:
    • Audit the entries and ensure corrections (if any) are performed as per ALCOA+ principles.
See also  Elixir Department: SOP for Storage of Raw Materials for Elixir Manufacturing - V 2.0

4. Accountability

The Production Head is accountable for ensuring that all dispensed quantities are accurately recorded and verified in the BMR in accordance with GMP documentation practices.

5. Procedure

5.1 Before Recording

  1. Ensure the correct BMR version is issued and the batch number is clearly mentioned.
  2. Cross-check the approved bill of materials and the actual materials dispensed against the Material Requisition Form.

5.2 Entry of Dispensed Quantities

  1. Record the following details in the “Material Dispensing Section” of the BMR:
    • Material Name
    • Material Code (if applicable)
    • Batch Number of Material
    • Quantity Required
    • Quantity Dispensed
    • Container Number(s)
    • Date and Time of Dispensing
    • Signature of Dispensing Operator
  2. Enter values in legible handwriting using a blue or black permanent pen.
  3. Do not overwrite; for corrections, strike a single line, write the correct value, and initial with date/time.

See also  Elixir Department: SOP for Use of Material Transfer Hatches - V 2.0

5.3 Review and Verification

  1. The Supervisor shall:
    • Verify that the actual quantity matches with batch requirement within allowable limits.
    • Ensure no unauthorized correction or tampering is observed.
    • Sign and date the verification section.
  2. QA shall:
    • Randomly check selected entries and ensure they match with the Dispensing Logbook and labels.
    • Initial and date the reviewed pages in the BMR.

5.4 Reconciliation Entry

  1. Record the reconciliation at the end of the dispensing table:
    • Total Quantity Required
    • Total Quantity Dispensed
    • Excess/Shortage (if any) with reason
  2. Sign and verify the reconciliation data with QA authorization.

6. Abbreviations

  • BMR: Batch Manufacturing Record
  • QA: Quality Assurance
  • GMP: Good Manufacturing Practice
  • ALCOA+: Attributable, Legible, Contemporaneous, Original, Accurate, Complete, Consistent, Enduring, and Available

7. Documents

  1. Batch Manufacturing Record (Annexure-1)
  2. Material Dispensing Log (Annexure-2)
  3. Verification and Reconciliation Sheet (Annexure-3)

8. References

  • 21 CFR Part 211 – Good Manufacturing Practice for Finished Pharmaceuticals
  • WHO TRS 996 Annex 5 – GMP for Documentation
See also  Elixir Department: SOP for Verification of Raw Material Identity and Quantity - V 2.0

9. SOP Version

Version: 2.0

10. Approval Section

Prepared By Checked By Approved By
Signature
Date
Name
Designation
Department

11. Annexures

Annexure-1: Batch Manufacturing Record – Material Entry Section

Material Code Batch No. Required Qty Dispensed Qty Container No. Dispensed By Date
Sodium Citrate SC001 SC2288 5.0 kg 5.0 kg 1 of 1 Rajesh Kumar 11/04/2025

Annexure-2: Material Dispensing Log

Date Material Batch No. Qty Dispensed By Verified By
11/04/2025 Sodium Citrate SC2288 5.0 kg Rajesh Kumar Sunita Reddy

Annexure-3: Verification and Reconciliation Sheet

Material Required Qty Dispensed Qty Reconciled Verified By
Sodium Citrate 5.0 kg 5.0 kg Yes Sunita Reddy

Revision History:

Revision Date Revision No. Revision Details Reason for Revision Approved By
01/01/2024 1.0 Initial SOP Release Document Creation QA Head
11/04/2025 2.0 Annexures and ALCOA+ Compliance Added Audit & Documentation Standardization QA Head
Elixers V 2.0 Tags:Elixir colorants, Elixir dosage form, Elixir filtration techniques, Elixir flavoring agents, Elixir formulation, Elixir GMP compliance, Elixir manufacturing process, Elixir manufacturing SOPs, Elixir packaging requirements, Elixir pharmacopoeial standards, Elixir preparation methods, Elixir preservatives, Elixir production equipment, Elixir quality control, Elixir regulatory guidelines, Elixir shelf life, Elixir stability testing, Elixir sterilization methods, Elixir storage conditions, Elixir sweetening agents, Elixir viscosity modifiers, Hydroalcoholic solutions, Medicated elixirs, Non-medicated elixirs, Pharmaceutical elixirs

Post navigation

Previous Post: API Manufacturing: SOP for In-Process Filtrate Clarity Testing – V 2.0
Next Post: BA-BE Studies: SOP for Cleaning and Disinfection of Dosing Rooms – V 2.0

Standard Operating Procedures V 1.0

  • Aerosols
  • Analytical Method Development
  • Bioequivalence Bioavailability Study
  • Capsule Formulation
  • Clinical Studies
  • Creams
  • Data Integrity
  • Dental Dosage Forms
  • Drug Discovery
  • Environment, Health and Safety
  • Formulation Development
  • Gels
  • Good Distribution Practice
  • Good Warehousing Practices
  • In-Process Control
  • Injectables
  • Liquid Orals
  • Liposome and Emulsion Formulations
  • Lotions
  • Lyophilized Products
  • Maintenance Dept.
  • Medical Devices
  • Metered-Dose Inhaler
  • Microbiology Testing
  • Nanoparticle Formulation
  • Nasal Spray Formulations
  • Nebulizers
  • Ocular (Eye) Dosage Forms
  • Ointments
  • Otic (Ear) Dosage Forms
  • Pharmacovigilance
  • Powder & Granules
  • Purchase Departments
  • Quality Assurance
  • Quality Control
  • Raw Material Stores
  • Regulatory Affairs
  • Tablet Manufacturing
  • Rectal Dosage Forms
  • Transdermal Patches
  • Vaginal Dosage Forms
  • Validations and Qualifications

Read SOPs in your Language:

 - 
Bengali
 - 
bn
English
 - 
en
Gujarati
 - 
gu
Hindi
 - 
hi
Malayalam
 - 
ml
Marathi
 - 
mr
Punjabi
 - 
pa
Tamil
 - 
ta
Telugu
 - 
te

NEW! Revised SOPs – V 2.0

  • Aerosols V 2.0
  • Analytical Method Development V 2.0
  • API Manufacturing V 2.0
  • BA-BE Studies V 2.0
  • Biosimilars V 2.0
  • Capsules V 2.0
  • Creams V 2.0
  • Elixers V 2.0
  • Ointments V 2.0
  • Raw Material Warehouse V 2.0
  • Tablet Manufacturing V2.0

New Publication: A must for All.

Copyright © 2025 SOP Guide for Pharma.

Powered by PressBook WordPress theme

Go to mobile version